Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Fresenius Biotech GmbH – Product Pipeline Review – Q1 2011

VIEWS: 5 PAGES: 31

Fresenius Biotech GmbH – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Fresenius Biotech GmbH - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Fresenius Biotech GmbH - Brief company overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Fresenius Biotech GmbH human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Fresenius Biotech GmbH with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Fresenius Biotech GmbH’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Fresenius Biotech GmbH’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Fresenius Biotech GmbH in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Fresenius Biotech GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opport

More Info
									 Fresenius Biotech GmbH – Product Pipeline Review –
                     Q1 2011
                                                                                          Reference Code: GMDHC0395CDB

                                                                                                Publication Date: MAR 2011




Fresenius Biotech GmbH – Product Pipeline Review – Q1 2011                                  GMDHC0395CDB / Published MAR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Fresenius Biotech GmbH – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        4
List of Figures                                                                                                       4
Fresenius Biotech GmbH Snapshot                                                                                       5
    Fresenius Biotech GmbH Overview                                                                                   5
    Key Information                                                                                                   5
    Key Facts                                                                                                         5
Fresenius Biotech GmbH – Research and Development Overview                                                            6
    Key Therapeutic Areas                                                                                             6
Fresenius Biotech GmbH – Pipeline Review                                                                              8
    Pipeline Products by Stage of Development                                                                         8
    Pipeline Products – Monotherapy                                                                                   9
    Pipeline Products – Combination Treatment Modalities                                                             10
Fresenius Biotech GmbH – Pipeline Products Glance                                                                    11
    Fresenius Biotech GmbH – Late Stage Pipeline                                                                     11
         Phase III Products/Combination Treatment Modalities                                                         11
    Fresenius Biotech GmbH Clinical Stage Pipeline Products                                                          12
         Phase II Products/Combination Treatment Modalities                                                          12
         Phase I Products/Combination Treatment Modalities                                                           13
Fresenius Biotech GmbH – Drug Profiles                                                                               14
    ATG-Fresenius S                                                                                                  14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    Removab + Prednisolone                                                                                           16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    Removab                                                                                                          17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    Rexomun                                                                                                          18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
    FBT-A05                                                                                                          19
         Product Description                                                                                         19
         Mechanism of Action                                                                                         19
         R&D Progress                                                                                                19
Fresenius Biotech GmbH – Pipeline Analysis                                                                           20
    Fresenius Biotech GmbH – Pipeline Products by Therapeutic Class                                                  20
    Fresenius Biotech GmbH - Pipeline Products By Target                                                             21
    Fresenius Biotech GmbH – Pipeline Products by Route of Administration                                            22
    Fresenius Biotech GmbH – Pipeline Products by Molecule Type                                                      23
Fresenius Biotech GmbH – Recent Pipeline Updates                                                                     24




Fresenius Biotech GmbH – Product Pipeline Review – Q1 2011                                GMDHC0395CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Fresenius Biotech GmbH – Product Pipeline Review



Fresenius Biotech GmbH – Locations And Subsidiaries                                                                  26
    Head Office                                                                                                      26
    Other Locations & Subsidiaries-                                                                                  26
Recent Developments                                                                                                  27
Financial Deals Landscape                                                                                            27
    Fresenius Biotech GmbH, Deals Summary, 2004 to 2011                                                              27
    Fresenius Biotech GmbH Detailed Deal Summary                                                                     28
         Licensing Agreements                                                                                        28
         Nabi Biopharmaceuticals Enters Into Agreement With Fresenius Biotech                                        28
Appendix                                                                                                             30
    Methodology                                                                                                      30
         Coverage                                                                                                    30
         Secondary Research                                                                                          30
         Primary Research                                                                                            30
         Expert Panel Validation                                                                                     31
    Contact Us                                                                                                       31
    Disclaimer                                                                                                       31




Fresenius Biotech GmbH – Product Pipeline Review – Q1 2011                                GMDHC0395CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(3)
Fresenius Biotech GmbH – Product Pipeline Review




Lis t o f Ta b le s
Fresenius Biotech GmbH – Pipeline by Therapy Area and Indication, 2011                                                                                                                         7

Fresenius Biotech GmbH – Pipeline by Stage of Development, 2011                                                                                                                                8

Fresenius Biotech GmbH – Monotherapy Products in Pipeline, 2011                                                                                                                                9

Fresenius Biotech GmbH – Combination Treatment Modalities in Pipeline, 2011                                                                                                                  10

Fresenius Biotech GmbH – Phase III, 2011                                                                                                                   
								
To top